NIAGEN BIOSCIENCE, INC. Share-based Payment Arrangement, Expense, after Tax
NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Payment Arrangement, Expense, after Tax of $700.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2020-03-10
- NIAGEN BIOSCIENCE, INC. share-based payment arrangement, expense, after tax for the quarter ending 2019-03-31 was $2.00M, a 53.85% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based payment arrangement, expense, after tax for the quarter ending 2018-12-31 was -$2.90M, a 182.86% decline year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based payment arrangement, expense, after tax for the quarter ending 2018-09-30 was $1.20M, a 200.00% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based payment arrangement, expense, after tax for the quarter ending 2018-06-30 was $1.80M, a 350.00% increase year-over-year.
- NIAGEN BIOSCIENCE, INC. share-based payment arrangement, expense, after tax for fiscal 2019 was $700.00K, a 46.15% decline from fiscal 2018.
- NIAGEN BIOSCIENCE, INC. share-based payment arrangement, expense, after tax for fiscal 2018 was $1.30M, a 71.74% decline from fiscal 2017.
- NIAGEN BIOSCIENCE, INC. share-based payment arrangement, expense, after tax for fiscal 2017 was $4.60M.
| Period end | Share-based Payment Arrangement, Expense, after Tax 3 month | Share-based Payment Arrangement, Expense, after Tax 3 month as first filed | Share-based Payment Arrangement, Expense, after Tax 6 month | Share-based Payment Arrangement, Expense, after Tax 6 month as first filed | Share-based Payment Arrangement, Expense, after Tax 9 month | Share-based Payment Arrangement, Expense, after Tax 9 month as first filed | Share-based Payment Arrangement, Expense, after Tax 12 month | Share-based Payment Arrangement, Expense, after Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | $700.00K 10-K · filed 2020-03-10 | |||||||
| 2019-03-31 | $2.00M 10-Q · filed 2019-05-09 | -$900.00K derived: sum of 2 quarters · filed 2020-03-10 | $300.00K derived: sum of 3 quarters · filed 2020-03-10 | $2.10M derived: sum of 4 quarters · filed 2020-03-10 | ||||
| 2018-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$1.70M derived: sum of 2 quarters · filed 2020-03-10 | $100.00K derived: sum of 3 quarters · filed 2020-03-10 | $1.30M 10-K · filed 2020-03-10 | $6.40M 10-K · filed 2019-03-07 | |||
| 2018-09-30 | $1.20M 10-Q · filed 2018-11-07 | $3.00M derived: sum of 2 quarters · filed 2018-11-07 | $4.20M 10-Q · filed 2018-11-07 | $7.80M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2018-06-30 | $1.80M 10-Q · filed 2018-08-09 | $3.00M 10-Q · filed 2018-08-09 | $6.60M derived: sum of 3 quarters · filed 2019-05-09 | $7.00M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2018-03-31 | $1.30M 10-Q · filed 2019-05-09 | $1.20M 10-Q · filed 2018-05-10 | $4.80M derived: sum of 2 quarters · filed 2019-05-09 | $5.20M derived: sum of 3 quarters · filed 2019-05-09 | $5.60M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-30 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $3.90M derived: sum of 2 quarters · filed 2019-03-07 | $4.30M derived: sum of 3 quarters · filed 2019-03-07 | $4.60M 10-K · filed 2019-03-07 | ||||
| 2017-09-30 | $400.00K 10-Q · filed 2018-11-07 | $800.00K derived: sum of 2 quarters · filed 2018-11-07 | $1.10M 10-Q · filed 2018-11-07 | |||||
| 2017-07-01 | $400.00K 10-Q · filed 2018-08-09 | $371.00K 10-Q · filed 2017-08-10 | $700.00K 10-Q · filed 2018-08-09 | $677.00K 10-Q · filed 2017-08-10 | ||||
| 2017-04-01 | $300.00K 10-Q · filed 2018-05-10 | $306.00K 10-Q · filed 2017-05-11 | ||||||
| 2016-10-01 | $300.00K 10-Q · filed 2017-11-09 | $260.00K 10-Q · filed 2016-11-10 | $614.00K derived: sum of 2 quarters · filed 2017-11-09 | $900.00K 10-Q · filed 2017-11-09 | $881.00K 10-Q · filed 2016-11-10 | |||
| 2016-07-02 | $314.00K 10-Q · filed 2017-08-10 | $621.00K 10-Q · filed 2017-08-10 | ||||||
| 2016-04-02 | $307.00K 10-Q · filed 2017-05-11 | |||||||
| 2015-10-03 | $418.00K 10-Q · filed 2016-11-10 | $860.00K derived: sum of 2 quarters · filed 2016-11-10 | $1.24M 10-Q · filed 2016-11-10 | |||||
| 2015-07-04 | $442.00K 10-Q · filed 2016-08-11 | $820.00K 10-Q · filed 2016-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |